ERBB2 and cancer: When SORLA was silenced in non-HER2-amplified but FGFR2-amplified MFM-223 breast cancer cells (Fig. 1a), there was no effect on cell proliferation (Supplementary Fig. 3g), indicating that SORLA is required for proliferation only in HER2-dependent cancer cells.